Factor, platelet-activating aspect, the TLR4 ligand LPS and also the TLR1 and
Element, platelet-activating aspect, the TLR4 ligand LPS as well as the TLR1 and TLR2 ligand Pam3CSK4 (N-palmitoyl-S-(2,3-bis(palmitoyloxy)-(2RS)-propyl)-(R)Cys-(S)-Ser-(S)-Lys4 trihydrochloride information not shown), modulated MICL plasma membrane expression. Similarly, we detected no…